Drug Type siRNA |
Synonyms DCRCOMP2, DRC COMP2 |
Target- |
Mechanism Complement activation inhibitors, RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Disorder of Complement | Preclinical | US | - | |
Disorder of Complement | Preclinical | US | - |